Association of three 8q24 polymorphisms with prostate cancer susceptibility: evidence from a meta-analysis with 50,854 subjects.

The 8q24 polymorphisms have been implicated in various cancers. Three 8q24 polymorphisms (rs1447295 C>A, rs16901979 C>A, and rs6983267 T>G) have been extensively investigated for their association with prostate cancer (PCa) susceptibility, yet conclusions are contradictory.

We conducted a comprehensive meta-analysis to reevaluate the associations between those polymorphisms and PCa susceptibility, according to the latest meta-analysis guidelines (PRISMA) Eligible publications were searched from MEDLINE, EMBASE and CBM False positive report possibility analysis was performed We totally collected 20184 cases and 20439 controls from 20 studies for the rs1447295 C>A, 1850 cases and 2090 controls from 7 studies for the rs16901979 C>A, and 12233 cases and 7582 controls from 17 studies for the rs6983267 T>G Overall, each of studied 8q24 polymorphisms was significantly associated with PCa risk individually Significant associations were also observed in stratified analysis by ethnicity, source of control, and quality score Interestingly, the effect of rs1447295 on PCa risk was observed among Caucasians and Asians, but not Africa-Americans The effect of rs16901979 was more prominent among Africa-Americans than Asians Likewise, rs6983267 conferred a higher Pca risk among Caucasians than Asians Collectively, these 8q24 variant(s) may modulate PCa risk in an ethnic-specific manner

Scientific reports 2015 Jul 10*** epublish ***

Qiaoxin Li, Xia Liu, Rui-Xi Hua, Feng Wang, Hengqing An, Wei Zhang, Jin-Hong Zhu

Department of Pathology, First Affiliated Hospital, Xinjiang Medical University, 137 Liyushan Road, Urumqi, Xinjiang, 830054, China , Department of Pathology, First Affiliated Hospital, Xinjiang Medical University, 137 Liyushan Road, Urumqi, Xinjiang, 830054, China , Department of Oncology, First affiliated Hospital of Sun Yat-Sen University, 58 Zhongshan Er Road, Guangzhou, Guangdong, 510080, China , Department of Uorology, First Affiliated Hospital, Xinjiang Medical University, 137 Liyushan Road, Urumqi, Xinjiang, 830054, China , Department of Uorology, First Affiliated Hospital, Xinjiang Medical University, 137 Liyushan Road, Urumqi, Xinjiang, 830054, China , Department of Pathology, First Affiliated Hospital, Xinjiang Medical University, 137 Liyushan Road, Urumqi, Xinjiang, 830054, China , Molecular Epidemiology Laboratory and Department of Laboratory Medicine, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, Heilongjang, 150040, China

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe